{
  "doc_id": "Mitochondrial-Neurogastrointestinal-Encephalopathy",
  "doc_filename": "Mitochondrial-Neurogastrointestinal-Encephalopathy.pdf",
  "top_entities": [
    {
      "name": "mitochondrial neurogastrointestinal encephalomyopathy",
      "mention_count": 2,
      "entity_type": "disease"
    },
    {
      "name": "diarrhea",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "Thymidine",
      "mention_count": 1,
      "entity_type": "drug"
    },
    {
      "name": "TYMP",
      "mention_count": 1,
      "entity_type": "gene"
    },
    {
      "name": "KIDINS220",
      "mention_count": 1,
      "entity_type": "gene"
    }
  ],
  "file_size_bytes": 2021,
  "file_size_human": "2.0 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "CRM",
  "document_type_name": "Clinical Research Materials",
  "document_type_group": "Clinical Research Materials",
  "classification_confidence": 0.15,
  "title": "Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): Clinical Overview",
  "short_description": "Clinical overview of MNGIE, a rare multisystem disorder characterized by gastrointestinal dysmotility, muscle weakness, and peripheral neuropathy caused by TYMP gene mutations.",
  "long_description": "This document provides a comprehensive clinical overview of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE), a rare autosomal recessive multisystem disorder. The text details the progressive nature of the condition, which primarily affects the gastrointestinal tract muscles leading to dysmotility, extra-ocular muscles causing ptosis and ophthalmoparesis, and peripheral nerves resulting in distal weakness and sensory alterations. The document outlines the variable clinical presentation including gastrointestinal symptoms such as vomiting, nausea, diarrhea, and abdominal pain, as well as neurological manifestations like numbness and paresthesias. It identifies the genetic basis of MNGIE as mutations in the TYMP gene encoding thymidine phosphorylase, providing essential information for understanding this complex mitochondrial disorder.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T01:38:31.512471"
}